Skip to main content

Amyloid Cardiomyopathy News

Related terms: Cardiomyopathy of Transthyretin-Mediated Amyloidosis, ATTR-CM

FDA Approves Attruby (acoramidis) to Reduce Cardiovascular Death and Cardiovascular-Related Hospitalization in Patients with ATTR-CM

PALO ALTO, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio or the Company), a new type of biopharmaceutical company focused on genetic diseases, today a...

Ask a question

To post your own question to our community, sign in or create an account.